Ubiquiti Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ubiquiti Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.57B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.93B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $1.94B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $1.69B | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $1.90B | Aug 25, 2023 |
| FY2020 | Jun 30, 2020 | $315.52M | Aug 21, 2020 |
| FY2020 | Mar 31, 2020 | $337.42M | Aug 21, 2020 |
| FY2020 | Dec 31, 2019 | $308.28M | Aug 21, 2020 |
| FY2020 | Sep 30, 2019 | $323.28M | Aug 21, 2020 |
| FY2020 | Jun 30, 2019 | $286.64M | Aug 21, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.57B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.93B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $1.94B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $1.69B | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $1.90B | Aug 25, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $228.62M | Aug 25, 2017 |
| FY2017 | Mar 31, 2017 | $218.36M | Aug 25, 2017 |
| FY2017 | Dec 31, 2016 | $213.54M | Aug 25, 2017 |
| FY2017 | Sep 30, 2016 | $204.76M | Aug 25, 2017 |
| FY2017 | Jun 30, 2016 | $185.68M | Aug 25, 2017 |
| FY2017 | Mar 31, 2016 | $167.43M | Aug 25, 2017 |
| FY2017 | Dec 31, 2015 | $161.87M | Aug 25, 2017 |
| FY2017 | Sep 30, 2015 | $151.42M | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $145.27M | Aug 22, 2016 |
| FY2016 | Mar 31, 2015 | $147.46M | Aug 22, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.12B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $739.76M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $760.73M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $669.81M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $912.28M | Aug 25, 2023 |
| FY2020 | Jun 30, 2020 | $152.06M | Aug 21, 2020 |
| FY2020 | Mar 31, 2020 | $159.64M | Aug 21, 2020 |
| FY2020 | Dec 31, 2019 | $145.09M | Aug 21, 2020 |
| FY2020 | Sep 30, 2019 | $151.39M | Aug 21, 2020 |
| FY2020 | Jun 30, 2019 | $132.94M | Aug 21, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $711.92M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $349.96M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $407.64M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $378.66M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $616.58M | Aug 25, 2023 |
| FY2020 | Jun 30, 2020 | $92.62M | Aug 21, 2020 |
| FY2020 | Mar 31, 2020 | $103.72M | Aug 21, 2020 |
| FY2020 | Dec 31, 2019 | $85.81M | Aug 21, 2020 |
| FY2020 | Sep 30, 2019 | $98.15M | Aug 21, 2020 |
| FY2020 | Jun 30, 2019 | $70.90M | Aug 21, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $836.28M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $499.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $544.57M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $462.26M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $742.59M | Aug 25, 2023 |
| FY2020 | Jun 30, 2020 | $118.10M | Aug 21, 2020 |
| FY2020 | Mar 31, 2020 | $127.36M | Aug 21, 2020 |
| FY2020 | Dec 31, 2019 | $112.05M | Aug 21, 2020 |
| FY2020 | Sep 30, 2019 | $120.69M | Aug 21, 2020 |
| FY2020 | Jun 30, 2019 | $100.89M | Aug 21, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $169.67M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $159.77M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $145.17M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $137.69M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $116.17M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $89.41M | Aug 26, 2022 |
| FY2021 | Jun 30, 2019 | $82.07M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $74.32M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $69.09M | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $57.77M | Aug 24, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $111.50M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $81.00M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $70.99M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $69.86M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $53.51M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $40.57M | Aug 26, 2022 |
| FY2021 | Jun 30, 2019 | $43.24M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $43.12M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $36.85M | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $33.27M | Aug 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $640.03M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $541.52M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | ($145.43M) | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $370.26M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $612.02M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $460.28M | Aug 26, 2022 |
| FY2021 | Jun 30, 2019 | $259.26M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $332.05M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $112.04M | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $197.51M | Aug 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $12.59M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $11.98M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $20.93M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $13.47M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $18.33M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $30.62M | Aug 26, 2022 |
| FY2021 | Jun 30, 2019 | $51.68M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $9.12M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $7.23M | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $6.25M | Aug 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.47B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.15B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $1.41B | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $844.71M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $890.99M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $737.45M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $875.87M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $1.02B | Aug 21, 2019 |
| FY2018 | Jun 30, 2017 | $972.71M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $747.11M | Aug 25, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $798.19M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.06B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $1.52B | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $1.23B | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $888.29M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $1.03B | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $776.59M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $706.83M | Aug 21, 2019 |
| FY2018 | Jun 30, 2017 | $370.95M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $306.73M | Aug 25, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $668.26M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $95.06M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | ($115.73M) | Aug 22, 2025 |
| FY2025 | Jun 30, 2022 | ($382.88M) | Aug 22, 2025 |
| FY2024 | Jun 30, 2021 | $2.70M | Aug 23, 2024 |
| FY2023 | Jun 30, 2020 | ($295.46M) | Aug 25, 2023 |
| FY2022 | Jun 30, 2019 | $99.28M | Aug 26, 2022 |
| FY2021 | Jun 30, 2018 | $315.75M | Aug 27, 2021 |
| FY2020 | Jun 30, 2017 | $601.76M | Aug 21, 2020 |
| FY2019 | Jun 30, 2016 | $440.38M | Aug 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $651.12M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $84.36M | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | ($120.51M) | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | ($383.11M) | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $2.64M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | ($295.98M) | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $98.82M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $315.28M | Aug 21, 2019 |
| FY2018 | Jun 30, 2017 | $601.16M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $440.29M | Aug 25, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $149.73M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $126.34M | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $114.83M | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $136.22M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $249.42M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $142.62M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $238.15M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $666.68M | Aug 21, 2019 |
| FY2018 | Jun 30, 2017 | $604.20M | Aug 24, 2018 |
| FY2018 | Jun 30, 2016 | $551.03M | Aug 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $250.00M | Aug 22, 2025 |
| FY2024 | Jun 30, 2024 | $708.13M | Aug 23, 2024 |
| FY2023 | Jun 30, 2023 | $1.08B | Aug 25, 2023 |
| FY2022 | Jun 30, 2022 | $468.75M | Aug 26, 2022 |
| FY2021 | Jun 30, 2021 | $493.75M | Aug 27, 2021 |
| FY2020 | Jun 30, 2020 | $655.00M | Aug 21, 2020 |
| FY2019 | Jun 30, 2019 | $497.50M | Aug 21, 2019 |
| FY2018 | Jun 30, 2018 | $487.50M | Aug 24, 2018 |
| FY2017 | Jun 30, 2017 | $257.25M | Aug 25, 2017 |
| FY2016 | Jun 30, 2016 | $203.50M | Aug 22, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 11 | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 5 | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | 6 | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | 6 | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | 9 | Aug 25, 2023 |
| FY2020 | Jun 30, 2020 | 1 | Aug 21, 2020 |
| FY2020 | Mar 31, 2020 | 1 | Aug 21, 2020 |
| FY2020 | Dec 31, 2019 | 1 | Aug 21, 2020 |
| FY2020 | Sep 30, 2019 | 1 | Aug 21, 2020 |
| FY2020 | Jun 30, 2019 | 1 | Aug 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 11 | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 5 | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | 6 | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | 6 | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | 9 | Aug 25, 2023 |
| FY2020 | Jun 30, 2020 | 1 | Aug 21, 2020 |
| FY2020 | Mar 31, 2020 | 1 | Aug 21, 2020 |
| FY2020 | Dec 31, 2019 | 1 | Aug 21, 2020 |
| FY2020 | Sep 30, 2019 | 1 | Aug 21, 2020 |
| FY2020 | Jun 30, 2019 | 1 | Aug 21, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 60.49M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 60.46M | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | 60.44M | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | 60.42M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | 62.58M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | 63.69M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | 69.47M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | 74.07M | Aug 21, 2019 |
| FY2018 | Jun 30, 2017 | 80.28M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | 81.67M | Aug 25, 2017 |